Cargando…
Disease inhibition by major histocompatibility complex binding peptide analogues of disease-associated epitopes: more than blocking alone
Peptide analogues of disease-associated epitopes were studied for inhibition of experimental allergic encephalomyelitis (EAE) and adjuvant arthritis (AA) in Lewis rats. EAE- and AA-associated analogues were selected as competitors because of their in vitro inhibitory activity on proliferation of enc...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2119353/ https://www.ncbi.nlm.nih.gov/pubmed/1380974 |
Ejemplares similares
-
Major histocompatibility complex conformational epitopes are peptide specific
Publicado: (1992) -
Decrypting the structure of major histocompatibility complex class I- restricted cytotoxic T lymphocyte epitopes with complex peptide libraries
Publicado: (1995) -
Low-Affinity Major Histocompatibility Complex–Binding Peptides in Type 1 Diabetes
por: James, Eddie A., et al.
Publicado: (2008) -
An insulin peptide that binds an alternative site in class II major histocompatibility complex
Publicado: (1996) -
Structural Features of Peptide Analogs of Human Histocompatibility Leukocyte Antigen Class I Epitopes That Are More Potent and Immunogenic than Wild-Type Peptide
por: Tangri, Shabnam, et al.
Publicado: (2001)